The French anti-doping laboratory of Chatenay-Malabry in September 2017 was provisionally suspended by the World Anti-Doping Agency (WADA).
This provisional suspension was imposed due to analytical issues self-reported to WADA by the laboratory.
The provisional suspension, which took effect on 24 September 2017, prohibits the Paris Laboratory from carrying out any anti-doping activities, including all analyses of urine and blood samples. The suspension will remain in place pending disciplinary proceedings being carried out by an independent Disciplinary Committee.
About World Anti-Doping Agency
• The World Anti-Doping Agency is a foundation initiated by the International Olympic Committee to promote, coordinate and monitor the fight against drugs in sports.
• The agency's key activities include scientific research, education, development of anti-doping capacities, and monitoring of the World Anti-Doping Code, whose provisions are enforced by the UNESCO International Convention against Doping in Sport.
• The agency was set up on 10 November 1999 in Lausanne, Switzerland, as a result of what was called the "Declaration of Lausanne." Since 2002, the organization's headquarters have been located in Montreal, Quebec, Canada.